Evonik Industries AG (FRA:EVK) has been given a consensus recommendation of “Hold” by the twenty brokerages that are covering the stock, MarketBeat reports. Three research analysts have rated the stock with a sell rating, six have given a hold rating and eleven have given a buy rating to the company. The average twelve-month price objective among brokers that have issued ratings on the stock in the last year is €33.87 ($40.32).
EVK has been the topic of several analyst reports. Baader Bank set a €38.00 ($45.24) price target on Evonik Industries and gave the company a “buy” rating in a report on Thursday, October 26th. Goldman Sachs Group set a €29.00 ($34.52) price target on Evonik Industries and gave the company a “neutral” rating in a report on Wednesday, October 11th. JPMorgan Chase & Co. set a €25.00 ($29.76) price target on Evonik Industries and gave the company a “sell” rating in a report on Friday, November 3rd. Berenberg Bank set a €37.00 ($44.05) price target on Evonik Industries and gave the company a “buy” rating in a report on Tuesday, November 7th. Finally, Kepler Capital Markets set a €31.00 ($36.90) price target on Evonik Industries and gave the company a “neutral” rating in a report on Tuesday, November 28th.
Evonik Industries (FRA:EVK) traded up €0.44 ($0.52) during trading hours on Monday, reaching €31.69 ($37.73). The company had a trading volume of 1,500 shares. Evonik Industries has a 12-month low of €26.78 ($31.88) and a 12-month high of €32.97 ($39.25). The firm has a market capitalization of $14,790.00 and a P/E ratio of 20.18.
Evonik Industries Company Profile
Evonik Industries AG engages in the specialty chemicals business worldwide. It operates through Nutrition & Care, Resource Efficiency, Performance Materials, and Services segments. The Nutrition & Care segment offers specialty chemicals, including amphoteric surfactants, ceramides, phytosphingosines, oleochemical quaternary derivatives, organically modified silicones, superabsorbents, amino acids and amino acid derivatives, synthesis products, pharmaceutical polymers, and DL-methionine for use in consumer goods, animal nutrition, and healthcare sectors.
Receive News & Ratings for Evonik Industries Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evonik Industries and related companies with MarketBeat.com's FREE daily email newsletter.